Vaccine advisers to the US Centers for Disease Control and Prevention may vote this week to make a major change to the ...

The direct-acting antiviral glecaprevir/pibrentasvir (Mavyret) was highly effective and well tolerated in adults with acute ...

For a decade now, the world has had highly effective medications for hepatitis C infections. In the United States, they’ve mostly been sitting on the shelf, according to a new study. These drugs, ...

Hepatitis C is an infection of the liver caused by the hepatitis C virus (HCV). Experts estimate that about 2.4 million people in the United States are living with hepatitis C—but that figure could be ...

W hen hepatitis C was first discovered in 1989, the virus was spread largely through blood transfusions, before the blood supply was regularly screened for the virus. Now, though, hepatitis C is ...

The CDC's vaccine advisory committee could vote this week to change hepatitis B vaccine recommendations for children. Here's ...

As RFK Jr.'s new vaccine panel ponders changing the hepatitis B vaccination schedule, some doctors recall past patients, ...

A federal vaccine advisory committee this week is expected to discuss whether newborns should still get the hepatitis B ...

Simple math illustrates the challenge facing U.S. taxpayers, consumers and insurers following the launch late last year of two expensive new drugs to treat hepatitis C. If all 3 million people ...

P eople who inject drugs are the fastest-growing group at risk for hepatitis C. And yet, after receiving a diagnosis, many struggle to find sympathetic care and support, from both healthcare providers ...

A group of advisers to the Centers for Disease Control and Prevention is preparing to vote on whether the agency should scrap ...

The American Hospital Association and several hospital systems are suing the Trump Administration over an upcoming 340B pilot ...